FOR IMMEDIATE RELEASE
Medidata Solutions to Present at CDISC Events in July
Regulatory Standard Leaders to Share Expertise on
Data Standards Implementation and Regulatory Submissions
NEW YORK, N.Y. – July 8, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that members of its management team will deliver the following presentations at key CDISC events in July:
English Speaking User Group Face to Face Meeting—The practical use of the CDISC standards: Define to ADaM
July 13th, 2010, Uxbridge, UK
Presentation: “Data Cleaning Strategies Using ODM”
Speaker: Andrew Newbigging, Vice President, Integrations Development and Richard Young, Director, Regional Sales, EMEA
Date & Time: Tuesday, July 13, 9:30 a.m. BST
The English Speaking User Group Face to Face Meeting focuses on the practical use of the CDISC standards starting with define.xml through to ADaM/SDTM. Focusing on a standard domain (VS - vital signs), the meeting day will feature a number of presentations from users at sponsor companies, CROs and software vendors describing experiences of implementing the standards. The emphasis of the day will be on the practical aspect rather than the theoretical. To learn more, please visit: The English Speaking User Group Face to Face Meeting.
CDISC Interchange Japan
July 20–21, 2010, Tokyo, Japan
Presentation: “Using CDASH Data Collection Forms for Automated SAE Reporting”
Speaker: Andrew Newbigging, Vice President, Integrations Development
Date & Time: Wednesday, July 21, 9:00 a.m. JST
CDISC Interchange Japan discusses CDISC standards and initiatives including: CDSIC SHARE, FDA’s data standards implementation plan for regulatory submissions and regional activities. The interchange emphasizes regulatory submission standards and effective, useful standards in the clinical trial processes in the United States, Europe and Japan. To learn more, please visit: CDISC Interchange Japan.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability. Medidata’s advanced solutions address key functions throughout the clinical development process including protocol development (Medidata Designer®), trial planning and management (Medidata Grants Manager®, Medidata CRO Contractor®), user and learning management (iMedidata™), randomization and trial supply management (Medidata Balance™), monitoring (Medidata Rave Monitor, Medidata Rave Targeted SDV), Serious Adverse Events capture (Medidata Rave Safety Gateway) and clinical data capture, management and reporting (Medidata Rave®). Our diverse customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.
Lois Paul & Partners